These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 21864346

  • 1. HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.
    Fun A, van Maarseveen NM, Pokorná J, Maas RE, Schipper PJ, Konvalinka J, Nijhuis M.
    Retrovirology; 2011 Aug 24; 8():70. PubMed ID: 21864346
    [Abstract] [Full Text] [Related]

  • 2. Resistance to Second-Generation HIV-1 Maturation Inhibitors.
    Urano E, Timilsina U, Kaplan JA, Ablan S, Ghimire D, Pham P, Kuruppu N, Mandt R, Durell SR, Nitz TJ, Martin DE, Wild CT, Gaur R, Freed EO.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30567982
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat.
    Margot NA, Gibbs CS, Miller MD.
    Antimicrob Agents Chemother; 2010 Jun 15; 54(6):2345-53. PubMed ID: 20308382
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro selection of clinically relevant bevirimat resistance mutations revealed by "deep" sequencing of serially passaged, quasispecies-containing recombinant HIV-1.
    Knapp DJ, Harrigan PR, Poon AF, Brumme ZL, Brockman M, Cheung PK.
    J Clin Microbiol; 2011 Jan 15; 49(1):201-8. PubMed ID: 21084518
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity.
    Müller B, Anders M, Akiyama H, Welsch S, Glass B, Nikovics K, Clavel F, Tervo HM, Keppler OT, Kräusslich HG.
    J Biol Chem; 2009 Oct 23; 284(43):29692-703. PubMed ID: 19666477
    [Abstract] [Full Text] [Related]

  • 12. Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.
    Aoki M, Venzon DJ, Koh Y, Aoki-Ogata H, Miyakawa T, Yoshimura K, Maeda K, Mitsuya H.
    J Virol; 2009 Apr 23; 83(7):3059-68. PubMed ID: 19176623
    [Abstract] [Full Text] [Related]

  • 13. Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage.
    Nowicka-Sans B, Protack T, Lin Z, Li Z, Zhang S, Sun Y, Samanta H, Terry B, Liu Z, Chen Y, Sin N, Sit SY, Swidorski JJ, Chen J, Venables BL, Healy M, Meanwell NA, Cockett M, Hanumegowda U, Regueiro-Ren A, Krystal M, Dicker IB.
    Antimicrob Agents Chemother; 2016 Jul 23; 60(7):3956-69. PubMed ID: 27090171
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A single G10T polymorphism in HIV-1 subtype C Gag-SP1 regulates sensitivity to maturation inhibitors.
    Ghimire D, Kc Y, Timilsina U, Goel K, Nitz TJ, Wild CT, Gaur R.
    Retrovirology; 2021 Apr 09; 18(1):9. PubMed ID: 33836787
    [Abstract] [Full Text] [Related]

  • 18. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E, Ablan SD, Mandt R, Pauly GT, Sigano DM, Schneider JP, Martin DE, Nitz TJ, Wild CT, Freed EO.
    Antimicrob Agents Chemother; 2016 Jan 09; 60(1):190-7. PubMed ID: 26482309
    [Abstract] [Full Text] [Related]

  • 19. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.
    Checkley MA, Luttge BG, Soheilian F, Nagashima K, Freed EO.
    Virology; 2010 Apr 25; 400(1):137-44. PubMed ID: 20172577
    [Abstract] [Full Text] [Related]

  • 20. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
    Adamson CS, Ablan SD, Boeras I, Goila-Gaur R, Soheilian F, Nagashima K, Li F, Salzwedel K, Sakalian M, Wild CT, Freed EO.
    J Virol; 2006 Nov 25; 80(22):10957-71. PubMed ID: 16956950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.